169 related articles for article (PubMed ID: 27197945)
1. The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Fowles JS; Dailey DD; Gustafson DL; Thamm DH; Duval DL
Vet Comp Oncol; 2017 Jun; 15(2):481-492. PubMed ID: 27197945
[TBL] [Abstract][Full Text] [Related]
2. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
3. Cancer and comparative imaging.
LeBlanc AK
ILAR J; 2014; 55(1):164-8. PubMed ID: 24936036
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Pathological, and Ethical Considerations for the Conduct of Clinical Trials in Dogs with Naturally Occurring Cancer: A Comparative Approach to Accelerate Translational Drug Development.
Regan D; Garcia K; Thamm D
ILAR J; 2018 Dec; 59(1):99-110. PubMed ID: 30668709
[TBL] [Abstract][Full Text] [Related]
5. Current Trends in Drug Sensitivity Prediction.
Cortes-Ciriano I; Mervin LH; Bender A
Curr Pharm Des; 2016; 22(46):6918-6927. PubMed ID: 27784247
[TBL] [Abstract][Full Text] [Related]
6. A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity.
Omeir R; Thomas R; Teferedegne B; Williams C; Foseh G; Macauley J; Brinster L; Beren J; Peden K; Breen M; Lewis AM
Chromosome Res; 2015 Dec; 23(4):663-80. PubMed ID: 25957863
[TBL] [Abstract][Full Text] [Related]
7. Comparative oncology: what dogs and other species can teach us about humans with cancer.
Schiffman JD; Breen M
Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056372
[TBL] [Abstract][Full Text] [Related]
8. Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.
Yoshitake R; Saeki K; Watanabe M; Nakaoka N; Ong SM; Hanafusa M; Choisunirachon N; Fujita N; Nishimura R; Nakagawa T
Vet J; 2017 Mar; 221():38-47. PubMed ID: 28283079
[TBL] [Abstract][Full Text] [Related]
9. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.
Zhu Z; Ihle NT; Rejto PA; Zarrinkar PP
BMC Genomics; 2016 Jun; 17():455. PubMed ID: 27296290
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based integrative medicine in clinical veterinary oncology.
Raditic DM; Bartges JW
Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):831-53. PubMed ID: 25174902
[TBL] [Abstract][Full Text] [Related]
11. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
[TBL] [Abstract][Full Text] [Related]
12. Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.
Nguyen SM; Thamm DH; Vail DM; London CA
Vet Comp Oncol; 2015 Sep; 13(3):176-83. PubMed ID: 23534501
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
14. Canine comparative oncology for translational radiation research.
Boss MK
Int J Radiat Biol; 2022; 98(3):496-505. PubMed ID: 34586958
[TBL] [Abstract][Full Text] [Related]
15. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
16. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.
Yang W; Soares J; Greninger P; Edelman EJ; Lightfoot H; Forbes S; Bindal N; Beare D; Smith JA; Thompson IR; Ramaswamy S; Futreal PA; Haber DA; Stratton MR; Benes C; McDermott U; Garnett MJ
Nucleic Acids Res; 2013 Jan; 41(Database issue):D955-61. PubMed ID: 23180760
[TBL] [Abstract][Full Text] [Related]
17. Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology.
London CA; Gardner H; Zhao S; Knapp DW; Utturkar SM; Duval DL; Chambers MR; Ostrander E; Trent JM; Kuffel G
Vet Comp Oncol; 2023 Dec; 21(4):565-577. PubMed ID: 37778398
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tumour resistance against chemotherapeutic agents in veterinary oncology.
Klopfleisch R; Kohn B; Gruber AD
Vet J; 2016 Jan; 207():63-72. PubMed ID: 26526523
[TBL] [Abstract][Full Text] [Related]
19. Canine tumors: a spontaneous animal model of human carcinogenesis.
Pinho SS; Carvalho S; Cabral J; Reis CA; Gärtner F
Transl Res; 2012 Mar; 159(3):165-72. PubMed ID: 22340765
[TBL] [Abstract][Full Text] [Related]
20. Species-specific properties and translational aspects of canine dendritic cells.
Qeska V; Baumgärtner W; Beineke A
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):181-92. PubMed ID: 23280245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
